Srinath Lingutla

Title: Innovations of Srinath Lingutla

Introduction

Srinath Lingutla is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of medical devices, particularly in the area of vascular access systems. With a total of 8 patents, his work has advanced the technology used in healthcare settings.

Latest Patents

Lingutla's latest patents include innovative devices such as pressure-regulating vial access devices and methods. This device features a piercing member that extends from a base of an insertion member and a reservoir. The design allows for the reservoir to be introduced to the vial when the piercing member is inserted, ensuring that the contents can be accessed safely. Additionally, a locking mechanism is incorporated to prevent accidental insertion or withdrawal of the device from the vial.

Another significant patent is related to self-priming systems and methods. This vascular access system is designed to efficiently remove gas and a piercing member from a catheter assembly. The system can operate to remove gas and a portion of the piercing member either concurrently or sequentially, enhancing the safety and effectiveness of vascular access procedures.

Career Highlights

Throughout his career, Srinath Lingutla has worked with prominent organizations such as Icu Medical Inc. and the University of Utah Research Foundation. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in medical technology.

Collaborations

Lingutla has collaborated with talented individuals in his field, including Bhupinder Chhikara and Brandon Eads. These partnerships have fostered a creative environment that has led to the development of groundbreaking medical devices.

Conclusion

Srinath Lingutla's contributions to the field of medical devices through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the healthcare industry positively.